<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02818478</url>
  </required_header>
  <id_info>
    <org_study_id>100.03</org_study_id>
    <nct_id>NCT02818478</nct_id>
  </id_info>
  <brief_title>Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis</brief_title>
  <acronym>PRO</acronym>
  <official_title>Patient Reported Outcome Measures Reported Into the Danish Arthritis Registry (DANBIO) Via Computer or Tablet at Home Versus Touch Screen at the Outpatient Clinic Among Patients With Axial Spondyloarthritis or Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henrik Gudbergsen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The DANBIO registry, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Parker Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate if electronic reporting of patient reported outcome measures from home is
      comparable to the traditional touch-screen solution to hospital among patients with
      rheumatoid arthritis and axial spondyloarthritis
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HAQ</measure>
    <time_frame>48 hours</time_frame>
    <description>The Health Assessment Questionnaire (HAQ) developed to retrieve quantitative information on outcomes among patients with rheumatoid arthritis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>100 mm VAS global</measure>
    <time_frame>48 hours</time_frame>
    <description>Assessed via a visual analogue scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>100 mm VAS pain</measure>
    <time_frame>48 hours</time_frame>
    <description>Assessed via a visual analogue scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>100 mm VAS fatigue</measure>
    <time_frame>48 hours</time_frame>
    <description>Assessed via a visual analogue scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BASDAI</measure>
    <time_frame>48 hours</time_frame>
    <description>The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) developed to retrieve quantitative information on outcomes among patients with Ankylosing Spondylitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BASFI</measure>
    <time_frame>48 hours</time_frame>
    <description>The Bath Ankylosing Spondylitis Functional Index (BASFI) developed to retrieve quantitative information on outcomes among patients with Ankylosing Spondylitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BASDAI 5 &amp; 6</measure>
    <time_frame>48 hours</time_frame>
    <description>Questions 5 and 6 in BASDAI</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Smoking questionnaire</measure>
    <time_frame>48 hours</time_frame>
    <description>Smoking habits (I currently smoke; if smoking, then how many cigarettes, pibes, cigarillos, cigars and/or cheroots per day / I smoke from time to time; less than 1 cigarettes, or an equivalent amount, per day / I have stopped smoking; year of cessation / I have never smoked)</description>
  </other_outcome>
  <other_outcome>
    <measure>Alcohol consumption (units consumed per week)</measure>
    <time_frame>48 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Exercise questionnaire</measure>
    <time_frame>48 hours</time_frame>
    <description>Level of exercise; &quot;exercise that causes an increased pulse and/or a feeling of being breathless&quot; (5 times per week / 3-4 times per week / 1-2 times per week / 1-2 times per month / no regular exercising / I do not exercise)</description>
  </other_outcome>
  <other_outcome>
    <measure>Medical conditions questionnaire</measure>
    <time_frame>48 hours</time_frame>
    <description>Diagnosis of other medical conditions; &quot;Has a doctor ever said that you have or have had the following diseases?&quot; (hypertension / diabetes / tuberculosis / angina / hypercholesterolemia / heart attack / brain haemorrhage / asthma / psoriasis / chronic bronchitis / osteoporosis / ulcer / liver disease / kidney disease / depression / inflammatory bowel disease or Crohns disease / cancer / multiple sclerosis / thyroid disease)</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Axial Spondyloarthritis</condition>
  <arm_group>
    <arm_group_label>RA; at home first</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients in this arm (10 patients with rheumatoid arthirtis, RA) will be randomised to initially fill in patient reported outcome measures from home via their own computer or tablet; subsequently these patients will fill in patient reported outcome measures at the outpatient clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RA; outpatient clinic first</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients in this arm (10 patients with rheumatoid arthirtis, RA) will be randomised to initially fill in patient reported outcome measures at the outpatient clinic; subsequently these patients will fill in patient reported outcome measures from home via their own computer or tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AxSpa; at home first</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients in this arm (10 patients with axial spondyloarthritis, AxSpa) will be randomised to initially fill in patient reported outcome measures from home via their own computer or tablet; subsequently these patients will fill in patient reported outcome measures at the outpatient clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AxSpa; outpatient clinic first</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients in this arm (10 patients with axial spondyloarthritis, AxSpa) will be randomised to initially fill in patient reported outcome measures at the outpatient clinic; subsequently these patients will fill in patient reported outcome measures from home via their own computer or tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reporting of patient reported outcome measures</intervention_name>
    <description>Electronic reporting of patient reported outcome measures from home, compared to reporting of patient reported outcome measures at the outpatient clinic</description>
    <arm_group_label>RA; at home first</arm_group_label>
    <arm_group_label>RA; outpatient clinic first</arm_group_label>
    <arm_group_label>AxSpa; at home first</arm_group_label>
    <arm_group_label>AxSpa; outpatient clinic first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Rheumatoid arthirtis OR axial spondyloarthritis

          -  Active treatment and monitoring of the Knowledge Center for Rheumatology and Spine
             diseases, Rigshospitalet, Denmark

          -  Patients must have reported patient reported outcome measures via DANBIOs touch-screen
             solution â‰¥ 3 times

        Exclusion Criteria

          -  Impaired vision

          -  Non-Danish speaking

          -  No electronic device at home,, tablet or computer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merete M Hetland, MD.PhD.DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2016</study_first_posted>
  <last_update_submitted>February 7, 2017</last_update_submitted>
  <last_update_submitted_qc>February 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Parker Research Institute</investigator_affiliation>
    <investigator_full_name>Henrik Gudbergsen</investigator_full_name>
    <investigator_title>EU Project Coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

